ZA978758B - Technetium-99m-labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents - Google Patents

Technetium-99m-labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents

Info

Publication number
ZA978758B
ZA978758B ZA978758A ZA978758A ZA978758B ZA 978758 B ZA978758 B ZA 978758B ZA 978758 A ZA978758 A ZA 978758A ZA 978758 A ZA978758 A ZA 978758A ZA 978758 B ZA978758 B ZA 978758B
Authority
ZA
South Africa
Prior art keywords
gpiib
technetium
bind
imaging agents
cyclic peptides
Prior art date
Application number
ZA978758A
Other languages
English (en)
Inventor
Milind Rajopadhye
Prahlad Ramadhar Singh
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of ZA978758B publication Critical patent/ZA978758B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/082Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being a RGD-containing peptide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/75Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA978758A 1996-10-02 1997-09-30 Technetium-99m-labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents ZA978758B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2735996P 1996-10-02 1996-10-02

Publications (1)

Publication Number Publication Date
ZA978758B true ZA978758B (en) 1999-03-30

Family

ID=21837260

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA978758A ZA978758B (en) 1996-10-02 1997-09-30 Technetium-99m-labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents

Country Status (7)

Country Link
US (1) US5888970A (xx)
EP (1) EP0993307A2 (xx)
JP (1) JP2001506583A (xx)
AU (1) AU727656B2 (xx)
CA (1) CA2267467A1 (xx)
WO (1) WO1998014220A2 (xx)
ZA (1) ZA978758B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083481A (en) * 1992-05-21 2000-07-04 Diatide, Inc. Thrombus imaging agents
DE19728524A1 (de) * 1997-07-04 1999-01-07 Merck Patent Gmbh Cyclische Azapeptide
US6524553B2 (en) 1998-03-31 2003-02-25 Bristol-Myers Squibb Pharma Company Quinolone vitronectin receptor antagonist pharmaceuticals
US6537520B1 (en) 1998-03-31 2003-03-25 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders
BR9909420A (pt) 1998-03-31 2001-09-25 Du Pont Pharm Co Composto, kit, composição metalofarmacêutica de diagnóstico ou terapêutica, composição de agente de contraste de ultrassom, composição radiofarmacêutica terapêutica e composição radiofarmacêutica de diagnóstico
US6548663B1 (en) 1998-03-31 2003-04-15 Bristol-Myers Squibb Pharma Company Benzodiazepine vitronectin receptor antagonist pharmaceuticals
US6522930B1 (en) 1998-05-06 2003-02-18 Atrionix, Inc. Irrigated ablation device assembly
CA2341672A1 (en) * 1998-10-13 2000-04-20 Milind Rajopadhye Chelator incorporated arg-gly-asp (rgd) mimetic synthetic disintegrins as imaging agents
US6511649B1 (en) 1998-12-18 2003-01-28 Thomas D. Harris Vitronectin receptor antagonist pharmaceuticals
EP1140203B1 (en) * 1998-12-18 2007-05-23 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
CN1356913A (zh) 1998-12-18 2002-07-03 杜邦药品公司 玻连蛋白受体拮抗剂药物
US6569402B1 (en) 1998-12-18 2003-05-27 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
EP1140864A2 (en) 1998-12-18 2001-10-10 Du Pont Pharmaceuticals Company Vitronectin receptor antagonist pharmaceuticals
US6794518B1 (en) 1998-12-18 2004-09-21 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
DK2658831T3 (en) * 2010-12-29 2017-04-24 Ge Healthcare Ltd elution

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
US5229363A (en) * 1991-02-19 1993-07-20 Merck & Co., Inc. Cyclic hexapeptide compounds
US5635477A (en) * 1991-09-30 1997-06-03 The Dupont Merck Pharmaceutical Company Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA
AU682857B2 (en) * 1993-03-29 1997-10-23 Du Pont Pharmaceuticals Company Novel processes and intermediate compounds for the preparation of platelet clycoprotein IIb/IIIa inhibitors
JPH08509709A (ja) * 1993-03-29 1996-10-15 ザ・デュポン・メルク・ファーマシュウティカル・カンパニー N▲上α▼−メチルアルギニンを含有する血小板糖たんぱく▲II▼b/▲III▼a抑制剤の製造方法およびそれに用いる中間体化合物
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
WO1995023811A1 (en) * 1994-03-04 1995-09-08 The Du Pont Merck Pharmaceutical Company Novel carbocyclic compounds which inhibit platelet aggregation by interaction with the gpiib/iiia receptor complex

Also Published As

Publication number Publication date
WO1998014220A2 (en) 1998-04-09
CA2267467A1 (en) 1998-04-09
AU4892597A (en) 1998-04-24
WO1998014220A3 (en) 1998-07-02
AU727656B2 (en) 2000-12-21
JP2001506583A (ja) 2001-05-22
US5888970A (en) 1999-03-30
EP0993307A2 (en) 2000-04-19

Similar Documents

Publication Publication Date Title
ZA978758B (en) Technetium-99m-labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents
IL146435A0 (en) Pharmaceutical compositions containing antibodies that bind to β-amyloid peptide
IL175399A (en) Antibodies binding to ob receptor variants
ZA978868B (en) Vaccine composition
HUP0203506A3 (en) Modified peptides as therapeutic agents
IL143797A0 (en) Human monoclonal antibodies to cytotoxic t lymphocyte antigen 4
FI955042A (fi) Syklosporiinia sisältävä jauhemainen koostumus
GB9619761D0 (en) Shampoo composition
GB9616351D0 (en) Vaccine composition
ZA979984B (en) Vaccine composition
SG77608A1 (en) Improvements relating to optical memories using electron trapping material
GB9923280D0 (en) Fabric care composition
PL335189A1 (en) Antiperspirant composition
IL145848A0 (en) Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus
IL145260A0 (en) Cosmetic stick composition
GB9801870D0 (en) Vaccine composition
GB9712410D0 (en) Peptides and compounds that bind to the il-5 receptor
AU7099900A (en) Peptides that bind to urokinase receptor
GB9929693D0 (en) Fabric care composition
EP1047714A4 (en) HUMAN CMRF-35-H9 RECEPTOR BINDING IgM
GB2241702B (en) Antibodies which bind to the stratum corneun and their use as drug vectors
GB9614618D0 (en) Vaccine compositions
GB9827506D0 (en) Peptides and compounds that bind to the il-5 receptor
GB9712383D0 (en) Peptides and compounds that bind to the IL-5 receptor
AU3125500A (en) Peptides and compounds that bind to the il-5 receptor